BioNexus Gene Lab Corp. Nontaxable Investment Securities Average Amount Outstanding
BioNexus Gene Lab Corp. (BGLC) reported Nontaxable Investment Securities Average Amount Outstanding of $39.25 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Banking and Thrift
us-gaap:NontaxableInvestmentSecuritiesAverageAmountOutstanding · last filed 2026-08-14
- BioNexus Gene Lab Corp. nontaxable investment securities average amount outstanding for the quarter ending 2026-06-30 was -$8.75K, a 380.30% decline year-over-year.
- BioNexus Gene Lab Corp. nontaxable investment securities average amount outstanding for the quarter ending 2026-03-31 was $48.00K, a 425.36% increase year-over-year.
- BioNexus Gene Lab Corp. nontaxable investment securities average amount outstanding for the quarter ending 2025-06-30 was $3.12K.
- BioNexus Gene Lab Corp. nontaxable investment securities average amount outstanding for the quarter ending 2025-03-31 was $9.14K.
- BioNexus Gene Lab Corp. nontaxable investment securities average amount outstanding for fiscal 2025 was $186.13K, a 24.23% increase from fiscal 2024.
- BioNexus Gene Lab Corp. nontaxable investment securities average amount outstanding for fiscal 2024 was $149.82K.
| Period end | Nontaxable Investment Securities Average Amount Outstanding 3 month | Nontaxable Investment Securities Average Amount Outstanding 6 month | Nontaxable Investment Securities Average Amount Outstanding 12 month |
|---|---|---|---|
| 2026-06-30 | -$8.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $39.25K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $48.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $186.13K 10-K · filed 2026-04-14 | ||
| 2025-06-30 | $3.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $12.26K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $9.14K 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $149.82K 10-K · filed 2026-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |